Trikafta—Extending Its Success to Less Common Mutations
Cystic Fibrosis (a genetic recessive disease) is caused by a mutant cystic fibrosis transmembrane conductance regulator (CFTR) gene that causes an absence of, or impaired CFTR activity [...]
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/9/1528 |
_version_ | 1797486001315119104 |
---|---|
author | Lea Bentur Mordechai Pollak |
author_facet | Lea Bentur Mordechai Pollak |
author_sort | Lea Bentur |
collection | DOAJ |
description | Cystic Fibrosis (a genetic recessive disease) is caused by a mutant cystic fibrosis transmembrane conductance regulator (CFTR) gene that causes an absence of, or impaired CFTR activity [...] |
first_indexed | 2024-03-09T23:27:53Z |
format | Article |
id | doaj.art-03e3dc9fd2b748f1b3c773a37d92b580 |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-09T23:27:53Z |
publishDate | 2022-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-03e3dc9fd2b748f1b3c773a37d92b5802023-11-23T17:14:45ZengMDPI AGJournal of Personalized Medicine2075-44262022-09-01129152810.3390/jpm12091528Trikafta—Extending Its Success to Less Common MutationsLea Bentur0Mordechai Pollak1Pediatric Pulmonary Institute, Ruth Children’s Hospital, Rambam Health Care Center, Haifa 31096, IsraelPediatric Pulmonary Institute, Ruth Children’s Hospital, Rambam Health Care Center, Haifa 31096, IsraelCystic Fibrosis (a genetic recessive disease) is caused by a mutant cystic fibrosis transmembrane conductance regulator (CFTR) gene that causes an absence of, or impaired CFTR activity [...]https://www.mdpi.com/2075-4426/12/9/1528n/a |
spellingShingle | Lea Bentur Mordechai Pollak Trikafta—Extending Its Success to Less Common Mutations Journal of Personalized Medicine n/a |
title | Trikafta—Extending Its Success to Less Common Mutations |
title_full | Trikafta—Extending Its Success to Less Common Mutations |
title_fullStr | Trikafta—Extending Its Success to Less Common Mutations |
title_full_unstemmed | Trikafta—Extending Its Success to Less Common Mutations |
title_short | Trikafta—Extending Its Success to Less Common Mutations |
title_sort | trikafta extending its success to less common mutations |
topic | n/a |
url | https://www.mdpi.com/2075-4426/12/9/1528 |
work_keys_str_mv | AT leabentur trikaftaextendingitssuccesstolesscommonmutations AT mordechaipollak trikaftaextendingitssuccesstolesscommonmutations |